493 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34591742 | An overview of alogliptin + pioglitazone for the treatment of type 2 diabetes. | 2022 Jan | 1 |
2 | 34713480 | Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. | 2022 Mar | 1 |
3 | 34718616 | TRIB3 Is Highly Expressed in the Adipose Tissue of Obese Patients and Is Associated With Insulin Resistance. | 2022 Feb 17 | 1 |
4 | 34863942 | The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease. | 2022 Jan | 1 |
5 | 35014161 | The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment. | 2022 Feb | 1 |
6 | 35059243 | The forgotten type 2 diabetes mellitus medicine: rosiglitazone. | 2022 Jan | 1 |
7 | 35434067 | Treatment and five-year follow-up of type A insulin resistance syndrome: A case report. | 2022 Mar 16 | 1 |
8 | 35581905 | T2DM Subgroups and Response to Glucose-lowering Therapy: Results from EDICT and Qatar Study. | 2022 May 17 | 1 |
9 | 33309864 | Pioglitazone Prevents Hemorrhagic Infarction After Transient Focal Ischemia in Type 2 Diabetes. | 2021 Sep | 3 |
10 | 33571166 | Pioglitazone does not synergize with mirabegron to increase beige fat or further improve glucose metabolism. | 2021 Mar 22 | 2 |
11 | 33638222 | Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia. | 2021 Jul | 1 |
12 | 33746449 | What Are the Current Pharmacological Therapies for Nonalcoholic Fatty Liver Disease? | 2021 Mar-Apr | 2 |
13 | 33880995 | Successful long-term use of pioglitazone in Berardinelli-Seip lipodystrophy-associated diabetes. | 2021 Apr 1 | 1 |
14 | 34006325 | Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug. | 2021 May 18 | 1 |
15 | 34311022 | Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial. | 2021 Aug | 2 |
16 | 34404415 | Combination of pioglitazone and clomiphene citrate versus clomiphene citrate alone for infertile women with the polycystic ovarian syndrome. | 2021 Aug 17 | 1 |
17 | 34483693 | Prominent Hyperproinsulinemia in a Middle Age Patient. | 2021 | 1 |
18 | 34511850 | Cardioprotective Effects of Pioglitazone in Type 2 Diabetes. | 2021 Aug | 1 |
19 | 34572374 | Pioglitazone Reverses Markers of Islet Beta-Cell De-Differentiation in db/db Mice While Modulating Expression of Genes Controlling Inflammation and Browning in White Adipose Tissue from Insulin-Resistant Mice and Humans. | 2021 Sep 10 | 3 |
20 | 34815985 | Multidimensional predictors of antidepressant responses: Integrating mitochondrial, genetic, metabolic and environmental factors with clinical outcomes. | 2021 Nov | 1 |
21 | 34925073 | The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans. | 2021 | 2 |
22 | 30663560 | Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice. | 2020 | 1 |
23 | 31339011 | Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study. | 2020 Feb | 2 |
24 | 32107266 | Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization. | 2020 Feb | 1 |
25 | 32252184 | Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects. | 2020 Mar | 1 |
26 | 32332780 | Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity. | 2020 Apr 24 | 2 |
27 | 32344313 | Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? | 2020 Jul | 1 |
28 | 32801814 | Association of TNF-α Gene Expression and Release in Response to Anti-Diabetic Drugs from Human Adipocytes in vitro. | 2020 | 1 |
29 | 32942898 | Pioglitazone. | 2020 Spring | 1 |
30 | 32963510 | Diet Modifies Pioglitazone's Influence on Hepatic PPARγ-Regulated Mitochondrial Gene Expression. | 2020 | 2 |
31 | 33040780 | Investigating the changes in the levels of HbA1c, blood fat and insulin sensitivity in elder patients with type II diabetes mellitus due to combined medication of pioglitazone and melbine and single-use of pioglitazone. | 2020 Sep 30 | 5 |
32 | 30259621 | Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin-treated T2DM patients: Results from the Qatar Study. | 2019 Mar | 3 |
33 | 30706731 | Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes. | 2019 Mar | 1 |
34 | 30729133 | High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone. | 2019 | 5 |
35 | 30734043 | Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial. | 2019 May 1 | 3 |
36 | 30738020 | Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease. | 2019 Jun | 2 |
37 | 31050706 | Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. | 2019 Dec 1 | 1 |
38 | 31117067 | Insulin Receptor and Glucose Transporters in the Mammalian Cochlea. | 2019 | 3 |
39 | 31129998 | Understanding Contemporary Use of Thiazolidinediones. | 2019 Jun | 1 |
40 | 31683341 | Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial. | 2019 Nov | 1 |
41 | 31827945 | Antibody-Mediated Extreme Insulin Resistance: The Importance of Pre-Treatment Screening. | 2019 | 1 |
42 | 28918389 | Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option. | 2018 Jan | 1 |
43 | 29040733 | Decreased incidence of gout in diabetic patients using pioglitazone. | 2018 Jan 1 | 1 |
44 | 29084736 | Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke). | 2018 Jan 30 | 4 |
45 | 29138876 | Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study. | 2018 Mar | 1 |
46 | 29223443 | Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. | 2018 Apr | 3 |
47 | 29227578 | Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study. | 2018 Apr | 3 |
48 | 29536426 | Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study. | 2018 Apr | 2 |
49 | 29580285 | Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance. | 2018 Mar 27 | 4 |
50 | 29786570 | Combination of metformin and pioglitazone and its effect in treatment of comorbid pathology. | 2018 | 2 |